Evidence map›Paper›PMID 38231127›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Neonatal CD8+ T Cells Resist Exhaustion during Chronic Infection.

Viviana I Maymí, Hongya Zhu, Mason Jager, Shawn Johnson, Rodman Getchell, James W Casey, Jennifer K Grenier, E John Wherry, Norah L Smith, Andrew Grimson and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Early-life human CD8Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Viviana I MaymíDepartment of Microbiology and Immunology, Cornell University, Ithaca, NY.ORCID 0000-0002-1575-3510
Hongya ZhuDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY.ORCID 0000-0003-1751-1782
Mason JagerDepartment of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY.ORCID 0000-0001-6036-9895
Shawn JohnsonDepartment of Microbiology and Immunology, Cornell University, Ithaca, NY.ORCID 0009-0008-6016-7837
Rodman GetchellDepartment of Microbiology and Immunology, Cornell University, Ithaca, NY.ORCID 0000-0003-4063-4668
James W CaseyDepartment of Microbiology and Immunology, Cornell University, Ithaca, NY.
Jennifer K GrenierTranscriptional Regulation and Expression Facility, Department of Biomedical Sciences, Cornell University, Ithaca, NY.
E John WherryInstitute for Immunology and Immune Health and Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Norah L SmithDepartment of Microbiology and Immunology, Cornell University, Ithaca, NY.ORCID 0000-0002-7495-7660
Andrew GrimsonDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY.
Brian D RuddDepartment of Microbiology and Immunology, Cornell University, Ithaca, NY.
Cornell University · USTranslational Therapeutics (United States) · US

Funding

Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunityP01AI108545 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI E. John Wherry · 2015 to 2026
$30.8M
Sequencing and Viral Evolution CoreU19AI117950 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WHERRY, E. JOHN · 2015 to 2019
$12.0M
Radiation and checkpoint blockade for cancer immune therapyP01CA210944 · NCI · UNIVERSITY OF PENNSYLVANIA · PI MAITY, AMIT, MINN, ANDY J · 2017 to 2022
$11.5M
The developmental layers in the CD8+ T cell response to chronic infectionR01AI110613 · NIAID · CORNELL UNIVERSITY · PI GRIMSON, ANDREW W, RUDD, BRIAN DAVID · 2014 to 2022
$4.1M
Mechanisms Limiting Neonatal ImmunityR01AI105265 · NIAID · CORNELL UNIVERSITY · PI RUDD, BRIAN DAVID · 2014 to 2023
$4.0M
Testing the role of BATF as a pioneer transcription factor in effector T cellsR01AI115712 · NIAID · DANA-FARBER CANCER INST · PI KADOCH, CIGALL, WHERRY, E. JOHN · 2015 to 2019
$2.9M
Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by ToxR01AI155577 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WHERRY, E. JOHN · 2020 to 2024
$2.7M
MicroRNAs in Tissue-resident memory T cellsR21AI166433 · NIAID · CORNELL UNIVERSITY · PI GRIMSON, ANDREW W, RUDD, BRIAN DAVID · 2022 to 2023
$438k
Regulation of CD8+ T cell exhaustion by let-7/Lin28b in different stages of lifeF30OD032097 · OD · CORNELL UNIVERSITY · PI Viviana Isabel Maymi · 2021 to 2026
$198k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI082630HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI105265HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI108545HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI110613HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI115712HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI117950HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI155577HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI166433HHS | NIH | NCI | Basic Research Laboratory (BRL) CA210944HHS | NIH | NIH Office of the Director (OD) AI167581NCI NIH HHS P01 CA210944NIAID NIH HHS P01 AI108545NIAID NIH HHS R01 AI105265NIAID NIH HHS R01 AI110613NIAID NIH HHS R01 AI115712NIAID NIH HHS R01 AI155577NIAID NIH HHS R21 AI166433NIAID NIH HHS U19 AI082630NIAID NIH HHS U19 AI117950NIH HHS F30 OD032097Parker Institute for Cancer Immunotherapy (Parker Institute)
6 · The paper itself

Abstract

Chronic viral infections, such as HIV and hepatitis C virus, represent a major public health problem. Although it is well understood that neonates and adults respond differently to chronic viral infections, the underlying mechanisms remain unknown. In this study, we transferred neonatal and adult CD8+ T cells into a mouse model of chronic infection (lymphocytic choriomeningitis virus clone 13) and dissected out the key cell-intrinsic differences that alter their ability to protect the host. Interestingly, we found that neonatal CD8+ T cells preferentially became effector cells early in chronic infection compared with adult CD8+ T cells and expressed higher levels of genes associated with cell migration and effector cell differentiation. During the chronic phase of infection, the neonatal cells retained more immune functionality and expressed lower levels of surface markers and genes related to exhaustion. Because the neonatal cells protect from viral replication early in chronic infection, the altered differentiation trajectories of neonatal and adult CD8+ T cells is functionally significant. Together, our work demonstrates how cell-intrinsic differences between neonatal and adult CD8+ T cells influence key cell fate decisions during chronic infection.

Indexed as

Lymphocytic ChoriomeningitisAnimalsCD8-Positive T-LymphocytesCell DifferentiationChronic DiseaseLymphocytic choriomeningitis virusMiceMice, Inbred C57BLPersistent Infection

Identifiers

PMID38231127
PMCPMC11298781
OpenAlexW4390942289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.